
IndraLab
Statements
reach
"The results from this study suggest that USP35 overexpression in ER+ breast cancer may confer resistance to ferroptotic insult by elevating GSH level via the BRD4-SLC7A11 axis.Our published work indicates that USP35 promotes the growth of ER+ breast cancer cells in vitro and in vivo, at least in part by affecting the G1 phase of cell cycle ."